This book presents current research in the study of the risk factors, management and complications of acute rejection in transplant patients. Topics include the mechanisms, management and consequences of acute cellular and antibody mediated rejection in solid organ and reconstructive transplantation; donor specific antibody mediated humoral rejection and biological implications of B cells; and, novel nucleic acid drugs for the prevention of acute cardiac rejection.